These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23880083)

  • 1. Exploring pyrimidine-substituted curcumin analogues: design, synthesis and effects on EGFR signaling.
    Qiu P; Xu L; Gao L; Zhang M; Wang S; Tong S; Sun Y; Zhang L; Jiang T
    Bioorg Med Chem; 2013 Sep; 21(17):5012-20. PubMed ID: 23880083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Chen A; Xu J; Johnson AC
    Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A; Xu J
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells.
    Qiu P; Wang S; Liu M; Ma H; Zeng X; Zhang M; Xu L; Cui Y; Xu H; Tang Y; He Y; Zhang L
    BMC Cancer; 2017 Jan; 17(1):55. PubMed ID: 28086832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.
    Lev-Ari S; Starr A; Vexler A; Karaush V; Loew V; Greif J; Fenig E; Aderka D; Ben-Yosef R
    Anticancer Res; 2006; 26(6B):4423-30. PubMed ID: 17201164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
    Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
    Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN
    Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel irreversible EGFR tyrosine kinase inhibitor 324674 sensitizes human colon carcinoma HT29 and SW480 cells to apoptosis by blocking the EGFR pathway.
    Yu Z; Cui B; Jin Y; Chen H; Wang X
    Biochem Biophys Res Commun; 2011 Aug; 411(4):751-6. PubMed ID: 21782788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity.
    Xu YY; Cao Y; Ma H; Li HQ; Ao GZ
    Bioorg Med Chem; 2013 Jan; 21(2):388-94. PubMed ID: 23245570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
    Lin R; Johnson SG; Connolly PJ; Wetter SK; Binnun E; Hughes TV; Murray WV; Pandey NB; Moreno-Mazza SJ; Adams M; Fuentes-Pesquera AR; Middleton SA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2333-7. PubMed ID: 19286381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling.
    Wang S; Yu S; Shi W; Ge L; Yu X; Fan J; Zhang J
    IUBMB Life; 2011 Sep; 63(9):775-82. PubMed ID: 22362715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.
    Song L; Morris M; Bagui T; Lee FY; Jove R; Haura EB
    Cancer Res; 2006 Jun; 66(11):5542-8. PubMed ID: 16740687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of dimethylaminomethyl-substituted curcumin derivatives/analogues: potent antitumor and antioxidant activity, improved stability and aqueous solubility compared with curcumin.
    Fang X; Fang L; Gou S; Cheng L
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1297-301. PubMed ID: 23357628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
    Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring stereoselectivity of 3-indolyl cyclopent[b]indoles: a parallel synthesis and anti-EGFR study on human cancer cells.
    Fan D; Sun W; Qiu P; Wu Z; Li Y; Wan S; Jiang T; Zhang L
    Eur J Med Chem; 2014 Mar; 74():533-40. PubMed ID: 24518873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin: a potential radio-enhancer in head and neck cancer.
    Khafif A; Lev-Ari S; Vexler A; Barnea I; Starr A; Karaush V; Haif S; Ben-Yosef R
    Laryngoscope; 2009 Oct; 119(10):2019-26. PubMed ID: 19655336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells.
    Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP
    Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
    Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
    Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
    Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
    Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.